Jonathan Lee, MD
Vascular Surgery · Springfield, NJNPI 1538664933
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (57.7%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Cagent Vascular Inc at 43.9% of the total. 2025 is the largest year on record at $6,739, 4.6 times the $1,464 reported in 2023.
Across 84 payments — averaging $142.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cagent Vascular Inc$5K
- Inari Medical, Inc.$2K
- Endologix LLC$863
- Bolton Medical Inc$584
- Penumbra, Inc.$500
- Cvrx, Inc.$473
- plus $3K from 15 others
What the payments were for
- Consulting fees$1,60013%
- Travel & lodging$3,44929%
- Food & beverage$6,89358%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cagent Vascular Inc | 19 | $5,239 |
| Inari Medical, Inc. | 12 | $1,760 |
| Endologix LLC | 8 | $863 |
| Bolton Medical Inc | 5 | $584 |
| Penumbra, Inc. | 5 | $500 |
| Cvrx, Inc. | 3 | $473 |
| Medtronic | 8 | $443 |
| Stryker | 5 | $435 |
| Silk Road Medical, Inc. | 3 | $318 |
| Convatec Inc. | 2 | $236 |
| Terumo Medical Corporation | 3 | $225 |
| W. L. Gore & Associates, Inc. | 1 | $189 |
| Angiodynamics, Inc. | 2 | $186 |
| Philips North America LLC | 1 | $165 |
| Acera Surgical, Inc. | 1 | $153 |
| Kerecis Limited | 1 | $45 |
| Limflow Inc. | 1 | $40 |
| Imperative Care, Inc | 1 | $31 |
| Lemaitre Vascular, Inc. | 1 | $23 |
| Abbott | 1 | $19 |
| Pfizer | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Serrantor$4,776
- CT THROMBECTOMY SYSTEM KIT$1,660
- FLOWTRIEVER CATHETER, S$1,660
- RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM$506
- Barostim Neo System$473
- ENROUTE Transcarotid Neuroprotection System$463
- Indigo System$332
- ENROUTE Transcarotid Stent$312
- AFX2 Bifurcated Endograft System$294
- LIMFLOW SYSTEM$267
- ENDURANT IIS$249
- Torus Stent Graft System$223
- ENDOCROSS Device$223
- Alto Abdominal Stent Graft System$209
- GORE VIABAHN VBX Balloon Expandable Endo$189
- (BR5) Peripheral IVUS$165
- Azur CX Detachable$159
- InnovaMatrix AC$158
- Restrata Wound Matrix$153
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$151
How this compares
$11,942 in reported general payments places this provider in the 70th percentile of 182 vascular surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $6,988 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $17 | $6,98812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 182 vascular surgery providers in New Jersey.
Other vascular surgery in Springfield
- Daniel FremedSpringfield$22K
- Michael AddisSpringfield$16K
- Steven EliasEnglewood$509K
- Michael WildermanHackensack$383K
- David O'ConnorHackensack$272K
- Joseph LombardiPomona$266K
- William BeckermanNew Brunswick$176K
- Neil PoulsenRockaway$148K
- Massimo NapolitanoWayne$147K
- Laurel HastingsCamden$98K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.